Publications by authors named "Matthew Arango"

Claim this Profile
B
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani

JAMA Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population.
Alycia Hatashima, Matthew J Arango, Joshua Reardon, Tracelyn Freeman, Terence Williams

Future Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience.
Justin C Tossey, Joshua Reardon, Jeffrey B VanDeusen, Anne M Noonan, Kyle Porter, Matthew J Arango

Med Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-Associated Thrombotic Microangiopathy: Response to Complement Inhibition and Reinitiation of Gemcitabine.
Jeffrey L Turner, Joshua Reardon, Tanios Bekaii-Saab, Spero R Cataland, Matthew J Arango

Clin Colorectal Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed presentation of nitroprusside-induced cyanide toxicity.
Chiedozie I Udeh, Michael Ting, Matthew Arango, Stephanie Mick

Ann Thorac Surg· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis